Approaching ASCO 2022: Collaborations in the Management of Bladder Cancer

Cheryl Lee, MD

Disclosures

May 26, 2022

In anticipation of the first in-person ASCO conference since the start of the COVID pandemic, Cheryl Lee, MD, considers several dimensions of the impending meeting, among them updates on novel therapies currently under investigation, and the opportunities such gatherings nurture regarding collaborations, both within the academy and extending outward into community-based organizations and industry.

Of special interest, Dr Lee highlights sessions on applications of AI and radiology, advances in molecular therapies, and challenging case studies in the management of bladder cancer.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....